Dealings in securities by a director and the company secretary and by directors of a major subsidiary LIFE HEALTHCARE GROUP HOLDINGS LIMITED (Incorporated in the Republic of South Africa) (Registration number: 2003/002733/06) ISIN: ZAE000145892 Share Code: LHC (“Life Healthcare” or “the Company”) DEALINGS IN SECURITIES BY A DIRECTOR AND THE COMPANY SECRETARY AND BY DIRECTORS OF A MAJOR SUBSIDIARY In compliance with the JSE Limited Listings Requirements, the following information is disclosed: Director : Petrus Phillippus van der Westhuizen Company : Life Healthcare Group Holdings Limited Nature of transaction : Off-market vesting of shares in terms of the Life Healthcare 2014 Long Term Incentive Plan (LTIP) and on-market disposal of the co-investment and Company matched shares and the co-investment and Company matched rights offer shares. Number of shares vested and sold : 19 890 (Co-investment and Company matched LTIP shares)* 6 806 (Co-investment and Company matched rights offer shares)** Vesting date : 31 January 2019 Date of transaction : 31 January 2019 Class of securities : Ordinary shares Volume weighted average price per : R27.2383 share Highest price : R27.78 Lowest price : R27.10 Total value of transaction : R727 153.66 Nature of interest : Direct Beneficial Clearance obtained : Yes Company Secretary : Fazila Patel Company : Life Healthcare Group Holdings Limited Nature of transaction : Off-market vesting of shares in terms of the Life Healthcare 2014 Long Term Incentive Plan (LTIP) and on-market disposal of the co-investment and Company matched shares and the co-investment and Company matched rights offer shares. Number of shares vested and sold : 12 092 (Co-investment and Company matched LTIP shares)* 4 137 (Co-investment and Company matched rights offer shares)** Vesting date : 31 January 2019 Date of transaction : 31 January 2019 Class of securities : Ordinary shares Volume weighted average price per : R27.2383 share Highest price : R27.78 Lowest price : R27.10 Total value of transaction : R442 050.37 Nature of interest : Direct Beneficial Clearance obtained : Yes Director : Pieter Francois Theron Company : Life Healthcare Group (Proprietary) Limited a major subsidiary of the Company Nature of transaction : Off-market vesting shares in terms of the Life Healthcare 2014 Long Term Incentive Plan (LTIP) and on-market disposal of the co-investment and ompany matched shares and the co-investment and Company matched rights offer shares. Number of shares vested and sold : 9 923 (Co-investment and Company matched LTIP shares)* 3 395 (Co-investment and Company matched rights offer shares)** Vesting date : 31 January 2019 Date of transaction : 31 January 2019 Class of securities : Ordinary shares Volume weighted average price per : R27.2383 share Highest price : R27.78 Lowest price : R27.10 Total value of transaction : R362 759.68 Nature of interest : Direct Beneficial Clearance obtained : Yes Director : Kurt Aston Wylie Company : Life Healthcare Group (Proprietary) Limited a major subsidiary of the Company Nature of transaction : Off-market vesting of shares in terms of the Life Healthcare 2014 Long Term Incentive Plan (LTIP) and on-market disposal of the co-investment and Company matched shares and the co-investment and Company matched rights offer shares. Number of shares vested and sold 6 175 (Co-investment and Company matched LTIP shares)* 2 113 (Co-investment and Company matched rights offer shares)** Vesting date : 31 January 2019 Date of transaction : 31 January 2019 Class of securities : Ordinary shares Volume weighted average price per : R27.2383 share Highest price : R27.78 Lowest price : R27.10 Total value of transaction : R225 751.03 Nature of interest : Direct Beneficial Clearance obtained : Yes Director : Craig Koekemoer Company : Life Healthcare Group (Proprietary) Limited a major subsidiary of the Company Nature of transaction : Off-market vesting of shares in terms of the Life Healthcare 2014 Long Term Incentive Plan (LTIP) and on-market disposal of the co-investment and Company matched shares. Prior to his appointment as a director of a major subsidiary of the Company, Mr Koekemoer elected to purchase 3 750 Life Healthcare shares on-market in terms of the LTIP in January 2017, at R35.0473 per share, and was awarded 6 356 Company matched shares in 2017, restricted for two years. In April 2017, Mr Koekemoer purchased 3 056 Life Healthcare shares off-market in terms of the rights offer in respect of the LTIP co-investment shares and the Company purchased 5 181 ordinary shares off-market in terms of the rights offer in respect of the LTIP Company matched shares. The rights offer price was R24.50 Number of shares vested and sold : 10 106 (Co-investment and Company matched LTIP shares) 3 458 (Co-investment and Company matched rights offer shares) Vesting date : 31 January 2019 Date of transaction : 31 January 2019 Class of securities : Ordinary shares Volume weighted average price per : R27.2383 share Highest price : R27.78 Lowest price : R27.10 Total value of transaction : R369 460.30 Nature of interest : Direct Beneficial Clearance obtained : Yes *Shareholders are referred to the SENS announcements published on 27 January 2017 where shareholders were advised that the chief financial officer, the company secretary and the directors of the major subsidiary had purchased a number of Life Healthcare shares on-market in terms of the LTIP. **Shareholders are referred to the SENS announcement published on 4 April 2017 where shareholders were advised that the chief financial officer, the company secretary and the directors of the major subsidiary had purchased a number of Life Healthcare rights offer shares off-market in terms of the LTIP. Illovo 4 February 2019 Sponsor RAND MERCHANT BANK (A division of FirstRand Bank Limited) Date: 04/02/2019 04:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.